ISSN: 1528-4336

Journal Home

Journal Guideline

HIV Clinical Trials Unclaimed

Taylor & Francis United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

HIV Clinical Trials is a journal indexed in SJR in Infectious Diseases and Pharmacology (medical) with an H index of . It has a price of 2395 €. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Infectious Diseases (-) Pharmacology (medical) (-)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

-

SJR Impact factor

-

H Index

-

Total Docs (Last Year)

-

Total Docs (3 years)

-

Total Refs

-

Total Cites (3 years)

-

Citable Docs (3 years)

-

Cites/Doc (2 years)

-

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Microbiology Q1
Clinical Microbiology Reviews Q1
The Lancet Infectious Diseases Q1
Cellular and Molecular Immunology Q1
Drug Resistance Updates Q1

Compare this journals

Aims and Scope

Best articles by citations

Usefulness of Therapeutic Drug Monitoring of Antiretrovirals in Routine Clinical Practice

Measuring Adherence to Antiretroviral Medications in Clinical Trials

Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients

Nelfinavir Plus Nevirapine Plus Two NRTIs As Salvage Therapy for HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment

Assessment of readiness to initiate antiretroviral therapy

Lipodystrophy in 685 HIV-1-Treated Patients: Influence of Antiretroviral Treatment and Immunovirological Response

When to Begin Treatment, When to Switch?: A Brief Summary of Discussions Between Clinicians, Researchers, and Statisticians at a Government-Sponsored Meeting

Benfluorex As a Therapeutic Option for Insulin Resistance in HIV Lipodystrophy Syndrome

Salvage therapy with amprenavir and ritonavir: Prospective study in 17 heavily pretreated patients

Salvage Therapy with Ritonavir-Boosted Amprenavir/Fosamprenavir: Virological and Immunological Response in Two Years Follow-up

Comparison of Neuropsychiatric Side Effects in an Observational Cohort of Efavirenz- and Protease Inhibitor-Treated Patients

Improving Participation in HIV Clinical Trials: Impact of a Brief Intervention

SHOW MORE ARTICLES

Hepatic and Renal Safety Profile of Tenofovir in HIV-Infected Patients with Hepatitis C, Including Patients on Interferon Plus Ribavirin

Salvage Treatment with Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients Failing All Current Antiretroviral Drug Families

Self-Reported Nonadherence with Antiretroviral Drugs Predicts Persistent Condition

Health-Related Quality of Life in HIV-Infected Naive Patients Treated with Nelfinavir or Nevirapine Associated with ZDV/3TC (the COMBINE-QoL Substudy)

Updated Guidelines for Managing HIV in Pregnancy from the USPHS Task Force

Nevirapine or Efavirenz Combined with Two Nucleoside Reverse Transcriptase Inhibitors Compared to HAART: A Meta-Analysis of Randomized Clinical Trials

Profile of HIV/AIDS Patients in a Tertiary Hospital in Istanbul, Turkey

Therapeutic Trials in HIV Infection: Which Benefits for Which Patients?

Study of the Validity of a Questionnaire to Assess the Adherence to Therapy in Patients Infected by HIV

Progression of Lipodystrophy (LD) with Continued Thymidine Analogue Usage: Long-Term Follow-Up from a Randomized Clinical Trial (The PIILR Study)

World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects Revised October 7, 2000

Bacterial Infections in Adult HIV-Infected Patients